Vividion Therapeutics

Acquired

Leading the small molecule Revolution

San Diego, United States · Founded 2016 · $368.0M raised

Employees
201–500
Founded
2016
Business Model
B2B
Total Funding
$368.0M
Last Round
$135.0M Series CFeb 2021
Rounds
4

About

Vividion Therapeutics is a San Diego-based biopharmaceutical company leveraging proprietary chemoproteomics technology to identify and drug previously undruggable protein targets for devastating cancers and immune disorders. Founded in 2016 as a spin-out of Scripps Research Institute, the company was acquired by Bayer AG in September 2021 for up to $2 billion and continues to operate as an autonomous subsidiary. Vividion has more than 200 employees and maintains active research and development programs.

Summary

Vividion Therapeutics is a Biotech company based in San Diego, United States, founded in 2016. It has raised $368.0M in total across 4 rounds, most recently a $135.0M Series C round in Feb 2021. Investors include Logos Capital, Boxer Capital and Nextech Invest.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CFeb 2021
$135.0M

Sign up to see all 4 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vividion Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/vividion-therapeutics"><img src="https://indexed.vc/api/badge/company/vividion-therapeutics" alt="Vividion Therapeutics on Indexed.vc" width="260" height="76" /></a>